Product image of Morphinsulfat Gry (Morphine Sulfate) supplied by GNH India

Morphinsulfat Gry

Active Ingredient:
Morphine Sulfate
Origin:
EU

Morphinsulfat Gry (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphinsulfat Gry, is an opioid analgesic presented as a sterile solution for epidural, intramuscular, and intravenous use. It provides potent pain relief for patients experiencing severe acute, postoperative, cancer‑related, or chronic severe pain.

GNH India supplies Morphinsulfat Gry as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics, and health‑care institutions worldwide. Our global distribution network ensures consistent product quality and regulatory compliance across EU and other markets. We adhere to stringent quality standards and provide technical support for safe clinical use.

Manufacturer / TM Owner

Teva Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Morphine Sulfate is used to manage severe pain across several clinical contexts.

  • Severe acute pain: provides rapid analgesia for trauma or sudden onset pain.
  • Post‑operative pain: reduces pain after surgical procedures.
  • Cancer‑related pain: alleviates persistent pain associated with malignancies.
  • Chronic severe pain requiring opioid therapy: offers long‑term control when other analgesics are insufficient.

How It Works

  • Morphine Sulfate acts as a full agonist at the µ‑opioid receptors located in the central nervous system and spinal cord. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to hyperpolarization of neurons. This suppresses nociceptive transmission and alters pain perception, producing analgesia and sedation. The effect is dose‑dependent and can be modulated by endogenous opioid peptides.

Side Effects

Morphine Sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: feeling of sickness or urge to vomit.
  • Constipation: reduced bowel movements.
  • Drowsiness: increased sleepiness or fatigue.
  • Miosis: pinpoint pupils.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing, potentially life‑threatening.
  • Hypotension: significant drop in blood pressure.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.

Precautions & Warnings

When prescribing Morphine Sulfate, clinicians should consider several safety precautions to minimize risks.

  • Assess pain severity and prior opioid exposure: determine appropriate indication and dosing.
  • Monitor respiratory function: watch for signs of depression, especially after dose changes.
  • Evaluate renal and hepatic function: adjust use in impairment.
  • Avoid use with other central nervous system depressants: increased risk of sedation and respiratory effects.
  • Educate patients on dependence and withdrawal: discuss safe use and tapering.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Morphine Sulfate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): may cause profound sedation and respiratory depression.
  • MAO inhibitors: can precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • SSRIs and other serotonergic agents: increase risk of serotonin syndrome.
  • Loop diuretics (e.g., furosemide): may enhance hypotensive effects.
  • Anticholinergics: may worsen constipation.

Frequently Asked Questions

Morphinsulfat Gry contains morphine sulfate, an opioid analgesic indicated for the management of severe acute pain, postoperative pain, cancer‑related pain, and chronic severe pain that requires opioid therapy when other analgesics are insufficient.

Morphine sulfate binds to µ‑opioid receptors in the brain and spinal cord, activating G‑protein pathways that inhibit neuronal firing. This reduces the transmission of pain signals and alters the perception of pain, producing strong analgesic and sedative effects.

The appropriate dose of Morphinsulfat Gry is individualized by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and overall clinical condition. No fixed dosing regimen is provided here.

Safety data for morphine sulfate in pregnancy and lactation are limited. It is generally classified as a drug to be used with caution, and the potential benefits must be weighed against possible risks to the fetus or infant by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Morphine sulfate is considered a benchmark opioid due to its well‑characterized efficacy and safety profile. Compared with newer synthetic opioids, it has a longer history of clinical use, predictable pharmacokinetics, and is often chosen when a reliable, potent analgesic is needed.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperature fluctuations to maintain sterility and potency.

Morphinsulfat Gry is supplied as a sterile solution for injection and may be given epidurally, intramuscularly, or intravenously by a qualified healthcare professional, following aseptic technique and appropriate dosing guidelines.

The most critical risks include respiratory depression, severe hypotension, and the potential for life‑threatening allergic reactions such as anaphylaxis. These events require immediate medical attention and close monitoring, especially after dose adjustments.

Patients with known hypersensitivity to morphine or any component of the formulation, those with significant respiratory compromise, untreated severe asthma, or acute head injury should avoid use. Clinicians must also assess for contraindications related to concurrent CNS depressants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.